Application 022071

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LAMISILTERBINAFINE HYDROCHLORIDEGRANULE;ORALEQ 125MG BASE/PACKETYesNo
002LAMISILTERBINAFINE HYDROCHLORIDEGRANULE;ORALEQ 187.5MG BASE/PACKETYesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
58167SUPPL2019-04-01
56373SUPPL2018-11-08
46957SUPPL2017-01-24
46947SUPPL2017-01-24
45230SUPPL2016-08-23
38192SUPPL2013-10-25
6827SUPPL2013-10-25
29202SUPPL2013-06-18
38191SUPPL2013-06-17
6826SUPPL2012-04-25
16894SUPPL2012-04-23
6825SUPPL2011-11-08
16893SUPPL2011-04-01
6824SUPPL2011-03-31
6823SUPPL2010-12-07
38190SUPPL2010-12-04
21926ORIG2009-03-12
38189ORIG2007-10-04
6822ORIG2007-10-04
53414ORIG1900-01-01
53413ORIG1900-01-01
53412ORIG1900-01-01